These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23157807)

  • 1. C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture.
    Cimmino G; Ragni M; Cirillo P; Petrillo G; Loffredo F; Chiariello M; Gresele P; Falcinelli E; Golino P
    Int J Cardiol; 2013 Sep; 168(2):981-6. PubMed ID: 23157807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
    Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
    Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells.
    Doronzo G; Russo I; Mattiello L; Trovati M; Anfossi G
    J Lab Clin Med; 2005 Nov; 146(5):287-98. PubMed ID: 16242528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
    Montero I; Orbe J; Varo N; Beloqui O; Monreal JI; Rodríguez JA; Díez J; Libby P; Páramo JA
    J Am Coll Cardiol; 2006 Apr; 47(7):1369-78. PubMed ID: 16580524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation.
    Gresele P; Falcinelli E; Loffredo F; Cimmino G; Corazzi T; Forte L; Guglielmini G; Momi S; Golino P
    Eur Heart J; 2011 Feb; 32(3):316-25. PubMed ID: 21036774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
    Chen N; Zhang JY; Yang SZ; Li YD
    J Biol Regul Homeost Agents; 2015; 29(2):437-41. PubMed ID: 26122234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
    Zayani Y; Allal-Elasmi M; Jacob MP; Zidi W; Zaroui A; Feki M; Mourali S; Mechmech R; Kaabachi N
    Clin Lab; 2013; 59(1-2):169-75. PubMed ID: 23505923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes.
    Forte L; Cimmino G; Loffredo F; De Palma R; Abbate G; Calabrò P; Ingrosso D; Galletti P; Carangio C; Casillo B; Calabrò R; Golino P
    Int J Cardiol; 2011 Oct; 152(1):7-12. PubMed ID: 21794939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
    Fiotti N; Altamura N; Orlando C; Simi L; Reimers B; Pascotto P; Zingone B; Pascotto A; Serio M; Guarnieri G; Giansante C
    Int J Cardiol; 2008 Jul; 127(3):350-7. PubMed ID: 17706812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
    Inokubo Y; Hanada H; Ishizaka H; Fukushi T; Kamada T; Okumura K
    Am Heart J; 2001 Feb; 141(2):211-7. PubMed ID: 11174334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
    Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
    Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
    Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical implications of increased cyclophilin A levels in patients with acute coronary syndromes.
    Yan J; Zang X; Chen R; Yuan W; Gong J; Wang C; Li Y
    Clin Chim Acta; 2012 Apr; 413(7-8):691-5. PubMed ID: 22209965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1.
    Nomoto K; Oguchi S; Watanabe I; Kushiro T; Kanmatsuse K
    J Cardiol; 2003 Nov; 42(5):201-6. PubMed ID: 14658408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.
    Kobayashi N; Takano M; Hata N; Kume N; Yamamoto M; Yokoyama S; Shinada T; Tomita K; Shirakabe A; Otsuka T; Seino Y; Mizuno K
    Int J Cardiol; 2013 Oct; 168(4):3217-23. PubMed ID: 23632121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques.
    Wang LX; Lü SZ; Zhang WJ; Song XT; Chen H; Zhang LJ
    Chin Med J (Engl); 2011 Jun; 124(11):1657-61. PubMed ID: 21740772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of atherosclerotic plaque stability and inflammation in the pathogenesis of acute coronary syndrome].
    Ding SF; Zhang Y; Zhang M; Chen WQ; Chen YG; Li JF; Ji QS; Li GS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):512-4. PubMed ID: 16842667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
    Giansante C; Fiotti N; Di Chiara A; Altamura N; Wasserman S; Fioretti P; Guarnieri G
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):602-7. PubMed ID: 17667031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.